ADPT - Adaptive Biotechnologies Announces Update to NCCN Guidelines® for Multiple Myeloma, Strengthening MRD Testing Recommendations and Specifically Referencing clonoSEQ®
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.